local glutathione reperfusion administration Frontiers International Journal of Molecular Medicine

Pritam et al

Disclosures: Toby Bradford: Nothing to Disclose, Natalie Torok: Nothing to Disclose 618 THE LIPIDOMIC PROFILE DISCRIMINATES BETWEEN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AND COMBINED METABOLIC DYSFUNCTION- AND ALCOHOL-RELATED STEATOTIC LIVER DISEASE Carolin Victoria Schneider 1 Rohit Loomba 2 Helen Huang 1 Anastasia Raptis 1 Kate Townsend Creasy 3 Jan Clusmann 1 Felix Van Haag 1 Tom Luedde 4 Sven Francque 5 Kai Markus Schneider 6 , 1 RWTH Aachen, 2 University of California, San Diego, 3 University of Pennsylvania, 4 University Hospital Duesseldorf, Heinrich Heine Universitt, 5 InflaMed Centre of Excellence, Laboratory for Experimental Medicine and Paediatrics, Translational S, 6 University Hospital Aachen Background: The recent multi-society Delphi consensus statement revised the nomenclature of steatotic liver disease to replace non-alcoholic fatty liver disease

This sleep hormone holds the key

doi: 10.3109/08860229809045088 102 GyurszovMGureckRBbkovJTthov

doi: 10.1016/j.cell.2023.03.008 118 CharabatiMZandeeSFournierAPTastetOThaiKZaminpeymaRet al